Top Markets
Coin of the day
UnitedHealth Group Incorporated UnitedHealth Group Incorporated

UnitedHealth Group Incorporated

UNH
Rank in Stocks #46
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare... UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
Share Price
$374.76
Market Cap
$340.34B
Change (1 day)
-0.54%
Change (1 year)
11.31%
Country
US
Trade UnitedHealth Group Incorporated (UNH)

Category

P/E ratio for UnitedHealth Group Incorporated (UNH)
P/E ratio as of September 2026 TTM: 24.66
According to UnitedHealth Group Incorporated latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 24.66. At the end of 2024 the company had a P/E ratio of 32.62.
P/E ratio history for UnitedHealth Group Incorporated from 2000 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 24.66 16.78%
2025 21.12 -35.27%
2024 32.62 49.45%
2023 21.83 -11.30%
2022 24.61 -10.16%
2021 27.39 27.19%
2020 21.54 6.61%
2019 20.20 0.93%
2018 20.02 -0.57%
2017 20.13 -7.29%
2016 21.71 12.58%
2015 19.29 10.29%
2014 17.49 29.85%
2013 13.47 33.60%
2012 10.08 -4.41%
2011 10.55 20.84%
2010 8.73 -6.30%
2009 9.31 -14.13%
2008 10.85 -33.89%
2007 16.41 -5.51%
2006 17.36 -31.90%
2005 25.50 19.68%
2004 21.30 2.53%
2003 20.78 10.83%
2002 18.75 -22.59%
2001 24.22 -10.39%
2000 27.03 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
24.95 1.15%
US
18.86 -23.55%
US
11.96 -51.51%
US
38.26 55.12%
US
- -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.